Table 4.

Baseline characteristics and treatment regimen, organized by response category during adrenocorticotropic hormone therapy

VariableSteroid Response Category (n)Age (yr)Sex (n)Race/Ethnicity (n)FSGS Morphology (n)Time from Diagnosis to Treatment (mo)Previous IMD (n)Creatinine (mg/dl)eGFR (ml/min per m2)Proteinuria (mg/d)IMD use during ACTH (n)Treatment Regimen (n)
Complete remission
(n=2)SR: 255 (40–69)M: 1
F: 1WNH: 2Tip: 295 (94–96)2: 1
4: 10.9 (0.6–1.2)82 (71–93)3215 (2100–4330)Yes: 0
No: 2Stanford (1) Columbia (1)
Partial remission(n=5)SR: 3 SD: 243 (21–64)M: 1
F: 4WNH: 3
BNH:1
BH: 1NOS: 2 Tip: 2 Cellular: 112 (2–56)1: 2
2: 1
3: 21.8 (1.1–3.6)49 (17–76)7849 (5046–15,200)Yes: 2
No: 3Stanford (2)
Columbia (1)
Individual (2)
Failed (n=17)SR: 9
SD: 5
NA: 344 (18–66)M: 12
F: 5WNH: 8
BNH: 2
WH: 7NOS: 6 Tip: 7 Cellular: 3 Collapsing: 131 (2–132)0: 2
1: 3
2: 5
3: 4
4: 32.1 (0.6–3.4)49 (17–124)3170 (1600–23,800)Yes: 2
No: 15Stanford (9)
Columbia (5)
Individual (3)
  • Values with ranges in parentheses are medians and interquartile ranges. IMD, immunosuppressive therapy; ACTH, adrenocorticotropic hormone; SR, steroid resistant; SD, steroid dependent; M, male; F, female; WNH, white non-Hispanic; BNH: black non-Hispanic; BH, black Hispanic; NOS, not otherwise specified; WH: white Hispanic.